Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.

Michele GhidiniHoward HochsterToshihiko DoiEric Van CutsemLukas MakrisOsamu TakahashiKarim A BenhadjiWasat Mansoor

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)

In TAGS, early BWL was a strong negative prognostic factor for OS in patients with mGC/GEJC receiving third- or later-line treatment.

Keyphrases

phase iii
prognostic factors
open label
clinical trial
double blind
weight loss
phase ii
placebo controlled
bariatric surgery
roux en y gastric bypass
type diabetes
replacement therapy
metabolic syndrome
randomized controlled trial
newly diagnosed
smoking cessation